Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents

Youngjae You1

  • 1Department of Chemistry, University at Buffalo, The State University of New York, Buffalo, NY 14260-3000, USA. yjyou@eng.buffalo.edu

Insights

Podophyllotoxin derivatives are explored for cancer treatment. New analogues and prodrugs aim for enhanced potency, tumor selectivity, and overcoming drug resistance, building on etoposide

Area of Science:

  • Natural Products Chemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Podophyllotoxin is a natural product with antimitotic properties.
  • It served as the basis for clinically used anticancer drugs like etoposide and teniposide.
  • These drugs function by inhibiting topoisomerase II, distinct from podophyllotoxin's mechanism.

Purpose of the Study:

  • To review current research trends in designing new podophyllotoxin derivatives.
  • To explore strategies for enhancing anticancer drug potency and overcoming resistance.
  • To discuss prodrug approaches for improved tumor selectivity and solubility.

Main Methods:

  • Structure-activity relationship studies to synthesize novel analogues.
  • Development of prodrug strategies for etoposide and related compounds.
  • Synthesis of diverse and complex podophyllotoxin derivatives.

Main Results:

  • Several potential drug candidates (e.g., GL-331, TOP 53) have been synthesized.
  • Newer analogues aim for increased potency and resistance circumvention.
  • Prodrug approaches show promise in enhancing tumor selectivity and solubility.

Conclusions:

  • Continued research into podophyllotoxin derivatives and prodrugs is crucial for developing more effective cancer therapies.
  • Novel synthetic strategies are yielding promising anticancer agents.
  • Prodrug modifications offer a viable route to improve the therapeutic index of existing drugs.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...